Communications

Advertising Communications Graphic Design Internet Marketing Media Publishing SEO
News Release Digital Asset Direct

Pending $400 Million Purchase Agreement To Advance Sharps Into Large Prefillable Syringe Market With Differentiated Copolymer Syringe Systems

Benzinga

By Meg Flippin, Benzinga Sharps Technology Inc. (NASDAQ: STSS) is an innovative medical device and pharmaceutical packaging company that seems positioned for growth through its commercial-ready, patented copolymer syringe products. The company recently announced a pending asset purchase agreement to acquire the InjectEZ specialty copolymer syringe manufacturing facility and a 10-Year purchase agreement for over $400 million from Nephron Pharmaceuticals, a privately held healthcare company. Sharps Technology has a stated mission to be a leader in the copolymer prefillable syringe system segment as the pharmaceutical industry shifts toward using these applications. The market opportunity that Sharps has identified, through target customers in the large-cap pharmaceutical and specialty biotech segments of the market, represents a significant opportunity for the company with opportunities for growth and profitability. The company says its advanced syringe offerings are easy to use and have built-in features to protect a person from needle stick injuries, blood-borne infections like hepatitis B and C and HIV. Vaccinations, medicine delivery and newly approved drug administration via the biotech industry are leading applications for Sharps’ syringes, and it’s a market growing at a CAGR of 11.95% from 2022 to 2030. Sharps’ Differentiated Products Are Stronger Than Glass When it comes to prefilled syringes, not all of them are created equal. Glass syringes have been the de facto standard but they have deficiencies that need to be overcome whether in a hospital setting or at home. For starters, glass syringes are prone to breakage as compared to Sharps’ COC (cyclic olefin copolymer) based prefilled syringes. Sharps’ copolymer products address many of the other historic deficiencies that glass-based syringes experience in the field. At present, COC syringes are comparable to glass in terms of barrier quality, long term drug stability and imperviousness to oxygen and water vapor contamination. They can exceed glass syringes in breakage rates, drug shelf life, cold chain storage, and cost to manufacture. Sharps’ product pipeline and market strategy will include a broad range of sizes, silicon free systems that address contamination issues for the healthcare market, dual chamber systems that improve drug shelf life while reducing unnecessary packaging and customized solutions for systems that serve the growing autoinjector segment. To further the market, Sharps recently inked a deal with Nephron Pharmaceuticals Corp. to make these advanced syringe systems. Nephron is a leader in contract manufacturing of generic medications and 503B outsourcing that includes extensive use of prefillable sterile syringes. Under the terms of the deal, Sharps will acquire Nephron’s InjectEZ specialty syringe manufacturing facility for $50 million. This includes a 10-year purchase agreement for over $400 million from Nephron Pharmaceuticals for Sharps’ next-generation copolymer prefillable syringe systems. Understanding The Prefillable Syringe Market The prefillable syringe market is a sub-industry within the healthcare sector that is growing faster than GDP at a 4x multiple of GDP. The U.S. market has seen growth over the past few years, driven by reducing hospital errors and administration injuries, increased use of biologics and biosimilars that require administration by injection, and need for more efficient drug delivery systems. Injectables were 37% of the global drug delivery market in 2017 and increased to 44% by 2021, even before COVID vaccines further increased syringe demand. Prefillable syringe capacity is at a premium, due to the global lack of capacity, increasing demand and technical challenges in production. Specifically, prefillable COC syringe demand growth is outstripping industry capacity. Additionally, these products are increasingly being used in the delivery of biologic drugs, biosimilars and in the development of new formulations of existing drugs. Larger molecules are becoming more complex and require exceptional delivery mechanisms. Copolymer Prefillable Syringes: A Niche Market That Seems To Be Taking Off The prefilled syringe market has growth prospects within the healthcare sector and Sharps will serve both Nephron and other pharmaceutical and healthcare customers within the copolymer segment of the market. With a lack of available capacity for these products and the technical challenges in producing them, Sharps says that it is at an advantage in the marketplace. The company has assembled a management team with a wealth of experience in developing copolymer syringes, which many rivals can’t claim. That’s evident with its Nexent line of syringes made of advanced polymer material for improved long-term drug stability and preserved efficacy. The material is also break-resistant and includes a robust container closure system utilizing common, industry standard rubber formulations, making it easier to pass regulatory scrutiny. Sharps sees a big market opportunity with its copolymer prefillable syringes including biologics and cold chain vaccines, serving potential customers in Japan, Europe, and North America, three regions with increasing demand through their rapidly aging populations. “With this landmark purchase agreement in place for our copolymer prefillable syringes, we will accelerate the realization of our shared goals, transition the company to revenue, and propel Sharps into a new phase of growth and sustainability,” commented Robert Hayes, Sharps CEO. “At the forefront of our growth trajectory are our copolymer-based prefillable syringe systems, a sector that is experiencing escalating market demand and is poised to shape the future of Sharps Technology.” To review the corporate website, CLICK HERE. To review the investors section for the website, CLICK HERE. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 29, 2023 09:25 AM Eastern Standard Time

Realbricks Is Unlocking High-Value Real Estate Investments For The Masses Through Fractional Ownership

Benzinga

By Faith Ashmore, Benzinga Begin your real estate investing journey on the Realbricks website! The world of real estate has long captivated investors looking for secure and profitable ventures. However, a new and exciting trend has emerged that appeals to a broader pool of investors with its promise of accessibility and diversification: fractional real estate. Fractional real estate fundamentally transforms the very notion of property ownership. Gone are the days when investors had to dedicate substantial resources to buy entire properties or rely solely on real estate investment trusts (REITs) for indirect exposure. Fractional ownership offers a unique solution, enabling individuals to own a fraction or share of a property, typically through digital platforms. This innovative model allows investors to purchase small portions of high-value properties, such as luxury vacation homes, commercial buildings or even residential complexes. The appeal lies in the opportunity for investors to gain exposure to previously inaccessible real estate markets, diverse property types and high-value assets that may have otherwise remained out of reach. In many ways, fractional ownership is democratizing the world of real estate. Historically, investing in real estate demanded significant financial resources, limiting this asset class mostly to the affluent. Fractional ownership now enables investors to participate in high-profile real estate ventures for a fraction of the price, opening doors to a wider investor base. The advent of online platforms and digital marketplaces has also streamlined the process, making investing in real estate as easy as a few clicks. With millennials increasingly disillusioned with traditional investment avenues, fractional real estate offers a fresh and exciting opportunity for them to diversify their portfolios and engage with tangible assets that resonate with their aspirations for financial growth. Not to mention, in an era marked by market volatility and an ever-changing economic landscape, fractional real estate provides a compelling solution to mitigate risk and enhance portfolio diversification. By diversifying their holdings across multiple properties, locations and asset classes, investors can minimize exposure to any single property or market downturn. Fractional ownership oftentimes eliminates the burden of day-to-day operations because it is typically accompanied by professional property management services. Fractional real estate investments can also generate consistent cash flow through rental income or profit-sharing models, providing stability and reducing dependence on the ebbs and flows of traditional financial markets. Among the companies that are facilitating this revolution is Realbricks, a proptech company that has recognized the increased opportunities that fractional real estate provides. The company created a platform that makes real estate investment accessible to anyone, anywhere – empowering all manner of investors to participate in the market. The company enables people to invest in vacation rentals like Airbnbs, long-term rentals, and multifamily properties without ever having to talk to a realtor. Its fractionalized approach to real estate investing means investors can gain access to properties that they would otherwise not have access to – with the ability to sell their shares at any time. The company’s platform integrates secondary markets and AI to provide investors with a comprehensive and efficient investment experience. With secondary markets, Realbricks allows investors to sell their ownership shares and access funds faster, providing liquidity to historically illiquid real estate assets. This integration enables investors to adjust their investments easily in response to changing circumstances, offering flexibility and adaptability. Realbricks also leverages AI to enhance the platform's capabilities. Through sophisticated algorithms, AI technology analyzes historical data, market trends and investor preferences to generate valuable insights. This integration of AI empowers investors with data-driven analysis, enabling them to gain a competitive edge in the competitive real estate market. Realbricks is also on the verge of expanding its offerings to include international investing, enabling investors to diversify their portfolios with properties from various continents without leaving their homes. This global perspective not only broadens investment options but also provides a layer of protection against localized economic challenges. A planned app launch in 2024 means the company – and potential real estate investors – have a lot to look forward to. At the heart of Realbricks' philosophy is a commitment to simplicity and security. Fractional real estate represents a revolutionary shift in the way investors engage with the real estate market. Its accessibility, diversification potential and ability to captivate younger generations make it one of the most intriguing investment avenues in recent times. By making real estate investment more accessible and convenient, Realbricks could be poised to revolutionize the industry and present a unique investment opportunity for individuals of all financial backgrounds. To learn more about Realbricks, click here. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 29, 2023 09:25 AM Eastern Standard Time

Active ETFs Appear Booming In 2023 — Tema ETFs Are Taking Them Into A New Direction

Benzinga

By Rachael Green, Benzinga The rapid emergence of the ETF industry, marked by its AuM growth from $1 trillion to $10 trillion this past decade, was driven by passive indexed funds which thrived in a low-rates, low-volatility environment. These funds offered low cost, low differentiation solutions to retail investors. As institutional investors overtake retail investors in ETF adoption, the landscape of the industry is set for a paradigm shift. The limitations of indexes are becoming increasingly apparent in a macro environment characterized by higher rates and higher volatility, which could stick around in the decade to come. The fundamental analysis and risk management that had been left behind by index funds are suddenly relevant again. Investors are consequently exploring alternative vehicles for their public equity exposures, namely active ETFs. Tema is one of the first independent thematic active ETF asset managers, but unlike competitors, is concentrating on underpenetrated, generational thematic trends that were previously inaccessible to investors. These themes include reshoring, oncology, luxury goods, cardiology and metabolics (Obesity and diabetes), and monopolies and oligopolies. The vulnerabilities of passive ETFs are becoming more apparent in the current environment Limited by the rigid nature of their underlying indices, passive funds lack the ability to dynamically respond and adapt to increasingly rapid and sharp changes in environment. These limitations undermine risk management efficacy and can ultimately compound risks for their investors. An example is the special premature rebalance the Nasdaq 100 index had to undergo this past summer. The disparity in performance within the index had over-concentrated its value, with the “Magnificent seven”, Alphabet (NASDAQ: GOOG), Amazon (NASDAQ: AMZN), Apple (NASDAQ: APPL), Meta (NASDAQ: META), Microsoft (NASDAQ: MSFT), Nvidia (NASDAQ: NVDA), and Tesla (NASDAQ: TSLA), reaching 55% of the index’s total value. The “special rebalance” not only revealed the concentration risks tied to indexation, but also exposed the arbitrage and front-running risks that passive vehicles can be exposed to, at the detriment of investors. Active ETFs have enjoyed record growth in 2023 While passive ETF growth has started to slow, active ETF growth is now accelerating fast, with over 20% of year-to-date asset flows. Yet the active space is still young, with only 5% of total ETF assets. “Active” simply indicates that a fund does not track an index, which gives issuers greater flexibility and creativity to build their products. These products have the potential to create more dynamic and precise exposures, and offer greater efficacy for risk management. The concerns with active management traditionally include higher fees, concentration risk, and ultimately disappointing performance. Tema believes a bottom-up approach to active management starting with risk management provides a proven and comprehensive solution to these latter concerns. Tema’s investment and risk management philosophy has an acute focus on mitigating downside risk. Previous academic studies have highlighted the underperformance of active management can largely be attributed to downside risk exposure. Active ETFs can allow for better risk management The discretion provided by active management allows Tema to proactively manage risk and capitalize on market dislocations in a disciplined way. For example, Tema’s risk management approach limits the size of any one company in a portfolio, thereby limiting concentration risk. Similarly, the flexibility of active management allows Tema to anticipate market events and position accordingly especially given the seasoned experience of Tema’s portfolio managers. This was evidenced most recently in the luxury space when Tema anticipated a Q3-2023 sell-off in luxury by increasing the cash position in the fund at the end of Q2-2023 to 20% temporarily. Tema ETFs focuses on themes with inherent indexation limitations Active management also provides the flexibility to access themes that are hard to index by nature of their constituents and underlying industries. Take for example Reshoring or Luxury, themes in which Tema launched the first US listed ETFs earlier this year. Tema’s American Reshoring ETF (NYSEARCA: RSHO), for example, seeks long-term growth by investing in companies that either enable the relocation of manufacturing and supply chains back to the United States or benefit from it. “Reshoring is a structural trend spurred by a confluence of factors including political and trade tensions, deglobalization and supported by unprecedented government spending. We think that reduced order cycles, lower inventories and more reliable supply chains should provide such companies with durable competitive advantages and higher sustainable growth outlooks,” said RSHO fund manager Chris Semenuk in a statement on the ETF’s launch. Reshoring companies are not clear-cut by nature of their industry classifications. As a result, reshoring beneficiaries and enablers are identified and analyzed based on bottom-up fundamental analysis that an index couldn’t replicate. Once the relevant securities have been selected, the portfolio construction follows a systematic approach which sizes positions based on conviction: highest, higher or foundational positions, depending on the manager’s relative confidence in that stock’s long-term potential. A similar bottom-up, innovative approach underpins Tema’s Luxury ETF (NYSEARCA: LUX) which invests in the global luxury industry. While luxury goods indexes exist, Tema saw a lack of precision in which companies are included in them. “We believe existing luxury investment indexes are undermined by construction issues and conflate bland consumer exposure with quality luxury exposure,” said Tema CEO Maurits Pot. “Furthermore, the luxury industry demonstrates high performance dispersion between longer-term outperforming and underperforming companies. While companies such as LVMH have generated consistent long-term returns for shareholders, companies such as Tods and Ferragamo have failed to generate shareholders for over ten years.” Luxury indices include mass consumer goods companies such as Apple or Nike which are fundamentally different to pure luxury brands such as Hermes or Louis Vuitton. Luxury brands are underpinned by exclusivity, aspirational desires and craftsmanship while mass consumer companies serve more functional and less aspirational roles. As a result, luxury companies have superior profitability, pricing power and different growth drivers. The Tema luxury ETF aims to provide pure, undiluted exposure to the luxury market. Tema’s other ETFs offer a similar level of expertise-driven thematic construction: The Monopolies and Oligopolies ETF (CBOE: TOLL) comprises companies operating in a monopolistic or oligopolistic industry structure. Monopolistic structures are defined by sustainable competitive advantages and high barriers to entry, typically leading to high margins and profitability. The Oncology ETF (NASDAQ: CANC) invests in oncology companies leading the fight against cancer. A revolution in biology and biotechnology is driving significant advances in diagnosing and treating cancer. The Global Royalties ETF (CBOE: ROYA) is made up of companies across a range of industries that are all extracting consistent revenue streams from royalties collected on natural resources, music catalogs, or pharmaceuticals. These unique and under-penetrated themes either cannot be accessed, or would have significant limitations if offered through an indexed vehicle. Access, precision, and risk management ae some of the clear benefits to Tema’s innovative approach. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 29, 2023 09:25 AM Eastern Standard Time

News Release

Hearing Necessary to “Shed Light” on Repeated Misrepresentations from Those Defending FOX from FCC Petition

Raynor Ave.

Supporters of the Media and Democracy Project’s (MAD) Petition to Deny the broadcast license renewal application for FOX Corp-owned television station FOX 29 Philadelphia (WTXF) submitted joint informal comments to the Federal Communications Commission (FCC) reiterating the evidence in support of holding a hearing into the matter. The supporters sought to address a series of misrepresentations circulating within the media and on Capitol Hill that follow from the same playbook FOX employed to undermine the 2020 election. Among other things, these comments clearly state that MAD’s petition is non-partisan and not about politics, not about speech, does not threaten Philadelphians’ access to Sunday Eagles NFL games, and will establish only an extremely narrow and limited precedent. The filing also called on the FCC to grant MAD’s motion to compel FOX to produce key discovery from recent litigations saying, “not requiring the production of those documents would be tantamount to looking the other way.” The group of seven—including former media veterans and FCC officials—concluded their filing with the following: “Because of Dominion record evidence (including internal emails and texts) the whole world watched Rupert Murdoch, Lachlan Murdoch, and FOX acknowledge the truth that the 2020 election was not stolen, debate the cost in viewers and revenues of reporting that truth to their viewers, and make a business decision to lie to them instead. The whole world also watched the tragic consequences of that business decision. Judge Davis called them out on it. The question is what the Commission will do.” To debunk scare tactics employed by Fox allies who have asserted FCC action against WTFX would deprive Philadelphians of the Eagles’ Sunday games, the commenters provided a declaration from former NFL media executive Frank Hawkins, who explained that in light of longstanding NFL TV contract provisions “[t]his assertion is at best uninformed, and at worst misinformation.” The joint informal comments were filed by Milo Vassallo, MAD’s Executive Director; Alfred Sikes, former Republican Chairman of the FCC; Ervin Duggan, former Democratic Commissioner of the FCC and former President of the Public Broadcasting Service; Jamie Kellner, Founding President of the Fox Broadcasting Company; William Kristol, former Editor of Rupert Murdoch’s The Weekly Standard; William Reyner, former Lead Regulatory and Commercial Counsel for Rupert Murdoch/News Corporation/Fox; and Preston Padden, former Executive of Fox Broadcasting Company and Former Lead Lobbyist for Rupert Murdoch/News Corporation/Fox. A copy of the joint informal comment is available here. A link to MAD’s initial Petition to Deny is available here. The Media and Democracy Project: MAD is a non-partisan, all-volunteer, grassroots organization focused on strengthening a free and independent media in the public interest. MAD aims to improve our national discourse so that American voters can engage in informed decision-making. As part of that goal, MAD has an interest in the responsibility of journalists and media to report fully, accurately, and fairly on the electoral process and the outcome of elections. Additional information is available at www.MediaAndDemocracyProject.Org. To sign up for more information from The Media and Democracy Project, click here. Contact Details Aaron Alberico +1 202-744-0786 aalberico@raynoravenue.com Company Website https://www.mediaanddemocracyproject.org/

November 29, 2023 08:30 AM Eastern Standard Time

Healthy Habits for your Family This Fall. Registered Dietician Nutritionist Provides Tips to Enhance Overall Wellness

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/Z87XU8x8YEU As the daylight hours get shorter and time spent outside exercising decreases, many people focus on their diets to stay healthy and happy throughout the coming months. The U.S. Department of Agriculture recommends eating meals made up of fruits, vegetables, lean meats, and low-fat dairy products. In fact, a healthy dietary pattern can benefit all individuals regardless of age, race, ethnicity, or current health status. For picky eaters, it is recommended that parents and caregivers continue to introduce new food and flavors, while being a role model with a healthy diet. A few core elements include vegetables of all types, dark green, red and orange, beans, peas, and lentils. Whole fruits are an important dietary staple, along with whole grains. Foods packed with protein, like poultry and eggs, seafood, nuts, and soy products have also been linked to healthier outcomes. Protein helps protect and build lean muscle mass, while promoting better brain chemistry. Fitness, wellness, and nutrition experts all agree that a balanced diet helps the brain function properly. B-vitamins are key nutrients needed for making the brain chemicals known to influence how awake and energized people feel in the morning. Optimal levels of serotonin require sufficient Vitamin D, B6, folate and amino acids. Syn has compiled a list of tips to help families enhance their nutrition and wellness plans throughout the fall and winter months. DAIRY ALTERNATIVES: Syn highlights the importance of moderation for everything we put into our bodies. That’s why she recommends starting the day with breakfast, while including Blue Diamond Almond Breeze Almondmilk. “It’s a perfect dairy milk alternative. I love how it tastes and it’s delicious in cereal and smoothies,” says Syn. Almond Breeze Almondmilk is nutritious and fortified with calcium and vitamins, while being free of gluten, lactose, saturated fat, and cholesterol. Among its wide portfolio of flavors, Almond Breeze comes in unsweetened varieties, including Unsweetened Original and Unsweetened Vanilla—with all the goodness of almonds. Direct link: https://www.bluediamond.com/brand/almond-breeze Social media handles: Facebook: Blue Diamond Almond Breeze Instagram: @almondbreeze X (Twitter): @AlmondBreeze FLAVORFUL CHOICES: As a Registered Dietitian Nutritionist, Syn, is always on the lookout for ways to enhance diets with a focus on health and wellness. She says juices are another way to add a little flavor into our daily routines. Wonder Beet, formally known as Beetology, is a cold pressed juice that champions the power of beets in four different ways. Wonder Beet, formerly Beetology™, champions the power of beets in four exceptional mixes: Beet + Lemon + Ginger, Beet + Veggie, Beet + Berry, and Beet + Cherry. Known as a high-nutrition, low-calorie superfood, beets are perfect for those seeking an all-natural boost of vitality for long-lasting, clean energy. These juices contain no artificial additives or added sugars. Syn says they are “Just pure, unadulterated 100% organic ingredients, ensuring every sip is delicious, satisfying, and curiously good." Wonder Beet is part of the Wonder Juiced esteemed beverage collection made up of 100% all-natural cold-press juices originating from organic farms and picked at peak freshness, These juices are high-nutrition and low-calorie. There are no artificial additives or added sugars – just 100% organic fruits and vegetables. A great way to enjoy great flavor while getting your vitamins from the fruit and veggies. In addition to juices, Syn has a set her sights on salads. She had a series on social media called, “Salads That Aren’t Boring.” Now, the nutritionist tries to turn a salad zero into a salad hero. Her number one tip, “It really comes down to choosing your favorite greens, fruits, and veggies,” adding, “It doesn’t have to be complex, but it’s often the dressing that makes a salad taste so good.” One of her go-to dressings is the all-natural Mighty Sesame Squeeze and Serve Organic Tahini. It is made with the highest quality sesame seeds sustainably sourced. Syn says Mighty Sesame Tahini has a delicious, creamy texture that is a “better for you choice” as a dressing, dip, or topping for wraps and sandwiches. She also points out how this dressing is packed with protein and calcium. Additionally, Mighty Sesame Tahini is vegan, gluten and dairy free, kosher and halal. Direct links: www.mightysesameco.com and www.drinkwonderjuices.com Social media handles: https://www.facebook.com/MightySesame/ https://www.instagram.com/mightysesameco/ Wonder Beet: https://www.facebook.com/drinkwonderjuices https://www.instagram.com/drinkwonderjuices/ FOODS PACKED WITH PROTEIN: Foods packed with protein have been linked to healthier outcomes. Syn says it’s a good idea to add more fish to your meal plans. MOWI is a leading farm-raised Atlantic Salmon producer and is boldly challenging the status quo within the seafood industry. The Salmon is BAP certified, which is one of the highest standards in sustainability in the seafood industry. Syn says this brand is of excellent taste and quality, adding “You can feel the delicate Omega 3 element and natural oil, which so good for you in salmon.” The Fresh MOWI Atlantic Salmon comes from the farm fresh, in optimum temperature, then freshly processed and packed with care in the United States. This product is available at nationwide retailers in only 24 hours from processing. Additionally, Syn points out that the salmon comes perfectly portioned in 6 oz. slices, whether seasoned or plain varieties. “It’s got a beautiful orange color, great marbling, moist and texture. And the best thing, it is fresh and has not been frozen,” says Syn. The Skin Pack technology allows the product to breathe out, but nothing breathes in, extending the products shelf life and reduces potential damage. Direct link: https://mowisalmon.us/ or www.decodingseafoodbymowi.us Social media handle: @mowisalmonus SUPPLEMENTS FOR THE ENTIRE FAMILY: More and more people are turning to supplements to get the proper nutrients they need into their diets, especially with nearly 9 out of 10 American children deficient in at least one key nutrient. SmartyPants is a premium gummy multivitamin brand on a mission to simplify health for the real world with high quality products that contain more nutrients to provide more comprehensive supplementation in one daily serving. Wherever possible, SmartyPants includes bioavailable forms of nutrients that are easier for your body to use and absorb. Syn says SmartyPants Vitamins is a must-have addition to your family’s daily routine this winter, with gummy multivitamins specifically formulated for Toddlers, Kids, Teens, and Adults. For example, SmartyPants Kids Multi & Omegas is made with over 15 nutrients, like Vitamin A, Vitamin B12, Vitamin B6, Vitamin C, Zinc and Vitamin D3 to support immune function. Additionally, SmartyPants Vitamins are tested & true, containing no synthetic colors and Certified Free from the 9 major allergens. All SmartyPants products are IGEN Non-GMO Tested and NSF Contents Certified, and Kids Multi & Omegas has a Clean Label Project Purity Award. The delicious gummies are also enjoyable to take for even the pickiest eaters with their great taste (like Lemon, Orange, and Strawberry Banana for the Kids Multi & Omegas). Direct links: smartypantsvitamins.com and https://www.amazon.com/stores/SmartyPantsVitamins/page/A04E4464-764A-4498-837B-AA3E3A765666?ref_=ast_bln Social media handles: Facebook: SmartyPants Vitamins Instagram: @smartypants X (Twitter): @SmartyHealth SNACK SMART: Research has found that about 60% of Americans are reducing sugar intake. Syn says that does not mean consumers have to stop snacking, they just need to snack smarter. A growing number of consumers are actively seeking ways to balance blood sugar levels, with #BloodSugar securing over 1 billion views on TikTok. To help address the need, Good Measure, a new food brand, has launched a portfolio of blood sugar-friendly snacks. The most popular Good Measure snack, the Peanut Butter & Dark Chocolate Nut Butter Bar, combines peanut chunks, seeds, dark chocolate, and rich peanut butter, resulting in a subtly sweet snack bar with creamy texture and a satisfying crunch. The holiday season can often mean overindulgence, but Good Measure Nut Butter Bars and Almond Crisps are conveniently portioned to help you control your intake and make mindful choices effortlessly. All Good Measure snacks contain five or fewer grams of Net Glycemic Carbs, ensuring little impact on blood sugar. Additionally, every snack is made with nutrient-rich ingredients to provide nutrition in every bite – all while keeping flavor front and center. Direct link: https://allingoodmeasure.com Social media handles: Facebook: Facebook Instagram: Instagram Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 28, 2023 03:00 PM Eastern Standard Time

Video

Melissa & Doug Toys Co-founder Introduces Lifelines, Well Being Tools That Activate Senses, Promote Stress Relief

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/ytMbkUGV8kg It’s no secret that stress relief can get stressful for many people. Science tells us that 80% of stress relief starts in your body, not your brain. What if there was a way to bring stress relief to your fingertips with a science-backed collection of physical tools designed to activate the nervous system's calming response. Melissa Bernstein, the creative Founder behind Melissa & Doug Toys, is introducing her newest venture, Lifelines, a collection of Sensory Immersion™ tools that activate the body's natural stress relievers, your senses. For more than 30 years, Melissa conceived over 10,000 toys designed to unleash children's imagination, but behind-the-scenes she hid a lifelong struggle with anxiety, depression and stress. When she immersed her senses - she was able to break the cycle of rumination and experience the present moment in totality. That is the backstory and inspiration for Lifelines. Lifelines will offer a comprehensive suite of Sensory Immersion tools across all six senses. The first collection is focused on aroma, a powerful and science-backed category Melissa felt lacked innovation. The collection includes 45 products with 16 patents pending, spanning portable fidget tools, sensory writing, innovative diffusers, and essential oil blends. There are over 100 new products in development, including meditative art activities for adults and multi-sensorial sound and sight devices. Lifelines Grounding Stones are patent-pending handheld diffusers designed for touch, combining the power of scent with fidgeting. Fidgeting has been scientifically proven to reduce stress and improve focus. The six unique and touchable designs feature an irresistible swivel and fit perfectly in the palm, for stress relief anytime, anywhere. Lifelines sensory writing tools inspire focus and spark creativity. The Scented Colored Pencils elevate any writing experience. And the Pen Diffuser combines an innovative writing tool with four distinct aromas dispensed at your fingertips. Tactile Sensory Journals feature covers made for touch, with soothing embossed patterns inside to keep your ideas flowing. Lifelines immersive diffusers pair with any of their 20 essential oil blends to activate smell, touch, and sight. The Waves Ultrasonic Diffuser combines breathtaking scents, colorful lights, and cascading mist inspired by the ocean's tides. The Shower Diffuser and Bath Diffuser turn any bathroom into a spa-like getaway. The portable and lightweight Everyday Diffuser fits perfectly into small spaces like a drawer, car or bag with no batteries or cords required. And then there are Lifelines Essential Oil Blends, thoughtfully crafted aromas inspired by nature and curated by Melissa. This includes more than 20 different blends across five intoxicating scent families and four well- being goals: Energy, Calm, Focus, and Joy. Blends are made from naturally derived, sustainably sourced botanicals, free from parabens and dyes, and blended in the USA. All oils come with Lifelines' patent-pending Precision Pump™ for a mess-free application that dispenses the perfect amount of oil every time. Lifelines products are affordably priced from $5.99-$29.99 and available at popular retailers nationwide including Target. For more information, visit Lifelines.com About Lifelines Founded in 2022, Lifelines, is a collection of Sensory Immersion™ tools that activate the body's natural stress relievers, the senses. From the creative mind of toy maker and play expert, Melissa Bernstein, Lifelines established a new category of adult well-being products that are affordably priced and accessible at major retailers nationwide. For more information visit www.Lifelines.com. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 28, 2023 03:00 PM Eastern Standard Time

Video

Knightscope 9-Month Financial Report: Company Triples Net Revenue, Reduces Backlog

Benzinga

By Faith Ashmore, Benzinga Click here to learn more about the Knightscope Public Safety Infrastructure Bond. Technology is advancing quicker than ever with robotics, AI and space technology becoming not just possible but integrated into everyday life. The robotics market was valued at $31.38 billion in 2021 and is expected to reach $110.39 billion by 2030 with a CAGR of 15% from 2022-2030. Similarly, the AI market had a valuation of $454.12 billion in 2022 and is projected to reach approximately $2,575.16 billion by 2032, with a CAGR of 19% between 2023 and 2032. While things like mainstream AI adoption raised questions just 10 years ago, it is undoubtedly the way of the future. One company, in particular, took a gamble ten years ago and started combining technology in multiple multi-billion dollar markets such as robotics, AI, electric vehicles (EV), telecommunications and autonomous tech. Knightscope (NASDAQ: KSCP) is a technology company ushering in the dawn of Autonomous Security Robots (ASRs) and working hard to protect U.S. citizens from crime across the country. Its robots are designed to deter, detect and report potential security threats, providing valuable situational awareness to security and public safety professionals. Q3 Earnings Report Knightscope reported financial results for the nine months ending on September 30th, 2023. The company's net revenue for this period was approximately $9.8 million, which is almost triple the $3.3 million reported during the same time frame in 2022. This translates to an annual revenue run rate of around $13 million, which is more than double the previous year's net revenue of $5.6 million. The backlog for the company as of October 29th, 2023 was approximately $4.1 million, reflecting a decrease from the previous quarter. The backlog is subject to fluctuations as new orders come in, and the company has made significant progress in reducing its backlog. Although the backlog for autonomous security robots slightly increased, the backlog for K1B products was reduced by approximately $1.1 million. Knightscope has been working to improve its production and supply chain processes to increase production output. With these efforts and the scaling up of operations, the company has improved its gross margins. During the first nine months of 2022, Knightscope had a gross loss of $2.1 million, while during the same period in 2023, the gross loss was only $154,000. The company expects to see continued improvements in the future as it executes its plan for profitability. The company's performance has also improved on a per-share basis. The loss per common share for the period decreased from $0.40 to $0.26. As of September 30th, 2023, Knightscope had cash and cash equivalents of $4.6 million, and on December 31st, 2022, it had $4.8 million. The company also fully extinguished convertible notes secured in connection with the acquisition of CASE emergency systems by the end of the second quarter of 2023. Bond Offering Knightscope recently launched its public safety infrastructure bond offering. It is offering 10% interest, paid in cash annually, on up to a 5-year bond. For example, a $10,000 investment could yield $1,000 of interest in cash payments annually for 5 years. The company plans to conduct rolling closes of the bonds on a monthly basis and successfully completed its initial closing a few weeks ago. Investors begin earning interest on their closing date, and the bond offering will remain active for several months as per Reg A+ offering regulations. Contracts Heading Into 2024 Knightscope’s success has garnered national attention, and the company has won corporate contracts with major corporations such as PENN Entertainment (NASDAQ: PENN), PG&E (NYSE: PCG), ABM (NYSE: ABM) and Lowe's (NYSE: LOW). The company also recently announced a collaboration with the NYPD and MTA in New York City, as their robots will operate in the subway system during late-night hours. Known for their effectiveness and approachability, the K5 robots strike a balance between engagement and respect for privacy. These partnerships are among a long list of other collaborations. Knightscope also offers an educational series about the increasing role robots are playing in the economy today and the company’s mission to “make the United States the safest country in the world.” Click here to learn more about the Rise of the Robots. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT IS AVAILABLE HERE. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 28, 2023 09:55 AM Eastern Standard Time

Harnessing The Power Of Gamma-Delta T Cells In Cancer Therapy: IN8bio’s Innovative Approach

Benzinga

By Faith Ashmore, Benzinga Why Are Gamma-Delta T Cells Important In Fighting Cancer? Gamma-delta T cells belong to a unique group of immune cells that have qualities of both the innate and adaptive immune systems. They have a complex set of receptors that allow them to differentiate between healthy and cancerous cells. Their multifunctional nature enables them to directly kill cancer cells and activate other immune cells to destroy tumors. What makes gamma-delta T cells particularly promising is that they can eliminate cancer cells without prior exposure to a specific antigen. This means they can trigger a more comprehensive immune response, making them valuable candidates for both solid and hematological cancer therapies. Gamma-delta T cells are also more durable than other innate immune cells like Natural Killer (NK) cells, which have shown to be less effective in clinical trials because of lack of persistence. How IN8bio’s Innovative Platform Helps Advance This Promising Research Field IN8bio's innovative DeltEx platform forms the basis of its extensive pipeline, comprising both preclinical and clinical product candidates. The platform is specifically designed to target cancer cells effectively, with the ultimate goal of potentially eradicating them and improving patient outcomes. Central to IN8bio's approach is their advanced expertise in genetically engineering and manufacturing ex-vivo, expanded and activated gamma-delta T cells. This expertise allows them to produce these immune cells in a way that enhances their therapeutic potential. In addition, IN8bio has developed proprietary gamma-delta T-cell engineering techniques that are unique to the field. This engineering is aimed at improving the cells' resistance to chemotherapy, making them even more effective in combating cancer. Another key feature of the DeltEx platform is the use of proprietary advanced, next-generation closed-system manufacturing technology. This scalable method enables the efficient production of gamma-delta T cells – ensuring a consistent and reliable supply for potential treatments. Importantly, IN8bio's engineered DeltEx cells show broad applicability across multiple types of cancers, both solid tumors and hematological malignancies. These unique properties have resulted in scientists focusing on developing cancer therapies based on gamma-delta T cells. It is projected that by 2028, the gamma-delta T cell cancer therapy market will be at $4 billion and one company seems to be leading the charge, IN8bio (NASDAQ: INAB). IN8bio is a biotechnology company that specializes in developing novel therapies based on gamma-delta T cells. Its innovative technology focuses on harnessing the potential of these cells to effectively target and eliminate cancer cells in both solid and hematological tumors. IN8bio's pipeline consists of a range of preclinical and clinical investigational therapies that aim to address various types of cancer with large unmet needs. Many of its lead product candidates are being developed for the treatment of patients with advanced solid tumors. The solid tumor market was valued at $209.61 billion in 2021, and it's expected to reach $901.27 billion by 2029. The drug candidate, INB-200, may be useful in treating solid tumors, including glioblastoma (GBM). GBM is a highly aggressive type of brain cancer with no cure, leading to a grim prognosis and an average overall survival time of only 14 to 16 months. INB-200 is a genetically modified autologous product candidate. This novel platform called drug-resistant immunotherapy, or DRI, utilizes genetic engineering to generate chemotherapy-resistant gamma delta T cells that can be administered concurrently with standard-of-care treatment in solid tumors. This is a powerful, synergistic treatment approach enabling gamma-delta T cells to persist in the presence of chemotherapy and maintain their natural ability to recognize, engage and kill cancer cells. It is designed to activate and expand Gamma-delta T cells in order to enhance the body's immune response against cancer. Leukemia, with a specific focus on Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), is another area of interest for IN8bio. The AML market is projected to to grow from $3.5 billion in 2022 to $6.1 billion in 2028 – representing a CAGR of 10%, while the MDS market which was worth $ 3.3 billion in 2022 is expected to exhibit a CAGR of 9.3% over 2023-2030. IN8bio's INB-100 is an allogeneic-derived, gamma-delta T cell product candidate aimed at addressing the unmet need in these areas. While there are some companies, such as Adicet (NASDAQ: ACET) and Century Therapeutics (NASDAQ: IPSC), studying gamma-delta T cells, IN8bio's DeltEx platform sets them apart from competitors in the field of cancer therapy. Its expertise, proprietary techniques, and scalable manufacturing process potentially position it as a leader in harnessing the potential of gamma-delta T cells for the development of innovative and effective cancer treatments. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 28, 2023 09:55 AM Eastern Standard Time

Lytus Digital Spearheads Lytus' Expansion Into The Next-Generation Technology Space

Benzinga

By Meg Flippin, Benzinga Macro headwinds may be impacting the economy along with geopolitical tensions, but that isn’t stopping businesses from looking to invest in their technology and IT solutions focused on business transformation and improved customer offerings. For 2023, worldwide IT spending is forecast to reach $4.6 trillion. Lytus Technologies recognizes the growing global demand for technology engineering services and aims to fulfill it through Lytus Digital. Driving a lot of that growth is spending on software. Forecasts estimate software sales will increase 12.3% in 2023 and 13.1% in 2024. Companies are looking to increase automation and productivity and are spending their investment dollars on software to achieve that. Need For Digital Transformation In recent years, digital business strategy has had a growing influence on overall business strategy which has resulted in companies leveraging technological solutions to transform their operations and improve their value proposition. A recent Gartner survey highlighted the demand for these services with 89% of board directors recognising the need for technological solutions but only 35% having achieved their digital transformation goals. Lytus Technologies’ new venture aims to serve the needs of the global SME sector which accounts for 90% of businesses and more than 50% of employment worldwide. Lytus Digital reports that it offers a suite of high-quality technology solutions that leverage several leading-edge technologies like cloud computing, wireless sensor networks and low-code rapid application development frameworks to address a wide range of enterprise pain points, and it makes these solutions accessible to a larger customer demographic across the globe. Winning Isn’t Easy Lytus Digital reports it is working on a range of exciting projects in its pipeline that address the major challenges faced by global enterprises in terms of building their digital presence, facilitating better business practices and improving customer interactions. The company is developing an ecosystem of customizable platforms focused on streamlining business process management, finance and compliance systems. This ecosystem will be integrated with The Next Generation E-commerce Platform featuring virtual and mixed-reality experiences. The company aims to remain at the forefront of innovation by leveraging deep tech like AI-assisted automation, computer vision machine learning and natural language processing. “Lytus Digital operates in a market where the barrier to entry is providing value to customers at aggressive thresholds,” said Lytus Digital’s Co-Head Jugal Gala when announcing the new offering. “Our in-house engineering capabilities will help us break into the market profitably. With this pursuit, we aim to establish strong partnerships in the industry to boost multinational growth, and to build accessible leading-edge technology-enabled products and solutions across various verticals.” Emerging Tech Brand By entering the technology engineering sector, Lytus is not just tapping an underserved need, but is positioning itself as an emerging competitive tech brand serving global markets The company’s business model is potentially disruptive but easily repeatable and scalable across geographies. Its recent launch of Lytus Studios is another example of how the company is leveraging technology to serve growing markets. Lytus Studios is a content creation and technology services business bringing virtual reality, augmented reality, mixed reality and extended reality to the film, video, commercial, corporate and digital markets. “This venture brings a strong tech native presence into our fold of companies and further strengthens Lytus’s ambitions to emerge as a leading technology brand in the global markets,” said Lytus Technologies CEO Dharmesh Pandya. “We are confident that the Lytus Digital team, with their strong engineering capabilities, will have a positive impact on our offerings and revenues.” Lytus Technologies is a platform services company enriching the experience for users whether it’s streaming content, telemedicine or fintech services. The company reports that its ability to provide a cutting-edge platform regardless of the digital offering is what makes it unique. The company operates telecasting, telemedicine and OTT platforms, leveraging its 5,000-kilometer network of installed fiber and broadband infrastructure to serve more than four million users in India and the USA. It's one of the few Indian companies listed on the NASDAQ. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 28, 2023 09:55 AM Eastern Standard Time

1 ... 48 49 50 51 52 ... 337